Skip to content
The Nexus
BUSINESSAug 3 · 12:12 UTCSTAT NEWSEd Silverman

STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states

Sandoz agreed to pay $478.5 million to settle allegations of price-fixing generic drugs, including $400 million over seven years to states and $28.5 million to resellers. The company denied wrongdoing as part of a long-running legal battle with states and resellers over inflated drug prices.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
SandozorganizationUS statesorganizationresellersorganizationGlenmark PharmaceuticalsorganizationLannettorganizationBauschorganizationApotexorganizationHeritage Pharmaceuticalsorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states · The Nexus